Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in 
mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene 
disruption.

Uhr, M.; Steckler, T.; Yassouridis, A.; Holsboer, F.

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption.

MPS-Authors

/persons/resource/persons80563

Uhr, M.
AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80601

Yassouridis, A.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80372

Holsboer, F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Uhr, M., Steckler, T., Yassouridis, A., & Holsboer, F. (2000). Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption. Neuropsychopharmacology, 22, 380-387.

引用: https://hdl.handle.net/11858/00-001M-0000-000E-A544-2

要旨

要旨はありません